Avalon GloboCare is a biotech company that develops diagnostics, cellular therapies, along with health tech products.
Avalon GloboCare has raised $9.8M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in February 2026.
Avalon GloboCare is headquartered in Freehold, United States.
Avalon GloboCare is a biotech company that develops diagnostics, cellular therapies, along with health tech products.
Avalon GloboCare is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Avalon GloboCare — Funding & Investors." VCBacked, February 26, 2026, https://www.vcbacked.co/company/avalon-globocare. Accessed August 14, 2026.
VCBacked. (2026). Avalon GloboCare — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/avalon-globocare
{{cite web |title=Avalon GloboCare — Funding & Investors |url=https://www.vcbacked.co/company/avalon-globocare |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated